Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics and Itopride in Irritable Bowel Syndrome
NCT04572932Completed
- Sponsor
- Ain Shams University
- Start
- May 2019
- Primary completion
- Dec 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised trial of lactobacillus delbrueckii and limosilactobacillus fermentum in irritable bowel syndrome (IBS), sponsored by Ain Shams University. Primary endpoint: Change of IBS Symptoms at 4 weeks. Started May 2019; status: completed.
02
Drugs
lactobacillus delbrueckiilimosilactobacillus fermentum
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT04572932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04572932.